Amplitude Surgical - Consolidated Annual Sales of €106.0m, up +6.3% at Constant Exchange Rates
25 Julio 2024 - 11:00AM
Business Wire
- Growth of 7.0% at constant exchange rates in the fourth quarter
of FY 2023-2024 and 6.3% for the full year
- 5.0% sales growth in France
- Good momentum outside France, with sales up 9.9% at constant
exchange rates
Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME
eligible), the French market leader in surgical technologies for
lower limb orthopedics, announces its consolidated sales for fiscal
year 2023-24.
Olivier Jallabert, Chief Executive Officer of Amplitude
Surgical, comments: "Group sales for the 2023-24 financial year
were up +6.3% at constant exchange rates on the previous year.
Amplitude Surgical has thus recorded another year of business
growth, both in France, with a +5.0% increase in sales, and
internationally, where sales momentum is up +9.9% at constant
exchange rates".
Consolidated sales for the 2023-2024 financial year
Sales
2023-24
30/06/2024
30/06/2023
Change at current exchange
rates
Change at constant exchange
rates
In € thousands - IFRS
Knee and hip activities
106,029
100,201
5.8%
6.3%
Total
106,029
100,201
5.8%
6.3%
Sales Q4
2023-24
30/06/2024
30/06/2023
Change at current exchange
rates
Change at constant exchange
rates
In € thousands - IFRS
Knee and hip activities
26,416
24,784
6.6%
7.0%
Total
26,416
24,784
6.6%
7.0%
In the 2023-24 financial year, Amplitude Surgical sales came to
€106.0 million, up 5.8% and 6.3% at constant exchange rates.
The Group's business growth is slightly below the 7% announced
in April 2024, as the last few months of activity in France were
punctually negatively impacted by strikes in some private clinics,
as well as by a drop in scheduling in the weeks preceding the
elections.
In FY 2023-24, sales in France rose by 5.0%, while international
distributors grew by 7.4% and the Group's international
subsidiaries by 8.1% at current exchange rates and 10.7% at
constant exchange rates.
Amplitude Surgical's direct sales (French market and
international subsidiaries), which account for almost 93% of total
Group sales, rose by +6.3% at constant exchange rates.
In France, the Group benefited from a favorable sales momentum
throughout the year, except in the last quarter. France accounts
for around 72% of Group sales.
For international subsidiaries, sales were up at constant
exchange rates in Belgium, Australia and Brazil, while sales in
Switzerland and South Africa were down.
Next press release:
Annual results 2023-24: Wednesday, October 23, 2024, after
market close.
About Amplitude Surgical
Founded in 1997 in Valence, France, Amplitude Surgical is a
leading French player in the global market for orthopedic surgical
technologies for the lower limbs. Amplitude Surgical develops and
markets high-end products for orthopedic surgery, covering the main
pathologies affecting the hip and knee. Working in close
collaboration with surgeons, Amplitude Surgical develops numerous
high value-added innovations to best meet the needs of patients,
surgeons and care facilities. A leading player in France, Amplitude
Surgical is expanding internationally through its subsidiaries and
a network of agents and exclusive distributors in over 30
countries. At June 30, 2024, Amplitude Surgical had 428 employees
and sales of nearly 106.0 million euros.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240725489139/en/
Amplitude Surgical Chief Financial Officer Dimitri
Borchtch finances@amplitude-surgical.com 04 75 41 87 41
NewCap Investor Relations Thomas Grojean
amplitude@newcap.eu 01 44 71 94 94
NewCap Media Relations Nicolas Merigeau
amplitude@newcap.eu 01 44 71 94 98
Amplitude Surgical (EU:AMPLI)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Amplitude Surgical (EU:AMPLI)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
